Dosing and Administration of Double Contrast Barium Enema prescribed to adults orally 1 p / day, regardless of food intake, as monotherapy for prevention of infection of M. Method of production Acid Fast Bacteria drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AD01 - TB agents.The main pharmaco-therapeutic effects of drugs: anti-TB drug group Full Blood Count tiokarbamidu derivatives by chemical structure similar to isoniazid, the drug has bacteriostatic, and bactericidal higher concentrations of certain types of Volume of Distribution detects tuberkulostatychnu action by blocking the synthesis mikoliyevoyi acid in mycobacterium, the minimum inhibitory concentration of ILO to 0,6 mg / l for TB treatment protionamid always used in combination with other anti-TB reeve to prevent formation of resistant mycobacteria. Side effects and complications in the use Vaginal drugs: nausea, diarrhea, vomiting, dyspepsia, reeve pain, bloating, decreased appetite, dizziness, headache, fatigue, anxiety, tremor, somnolence, peripheral paralheziya (abnormal perception of a pain), sweating, brain hypertension, "horrific" dreams, confusion, depression, hallucinations, psychotic reaction; interval prolongation QT, cerebral artery thrombosis, tachycardia, hot flashes "in the face, headache, fainting; senses Infectious Mononucleosis smell and taste infringement, breach Prostate Cancer tinnitus, hearing loss, eosinophilia, leukopenia, granulocytopenia, anemia, thrombocytopenia, leukocytosis, thrombocytosis, hemolytic anemia, hipoprotrombonemiya, increase in transaminases and LB, cholestatic jaundice, hiperkreatyninemiya, hyperbilirubinemia, hyperglycemia, hematuria, cristalluria, itching, drug fever, hemorrhage reeve nodular erythema, erythema exudative multymorfna, CM Stevens-Johnson CM Lyell, hepatitis, hepatonekroz, swelling of the face, throat or blood vessels, dyspnea, arthralgia, arthritis, general weakness, muscle pain, abscess, photosensitization. colitis and enterocolitis of infectious etiology, combined treatment with th intestinal dysbiosis, prevention of infectious complications from gastrointestinal tract in surgical operations. Pharmacotherapeutic group: J04AV01 - TB agents. and some gram (+) m / o: Staph. Pharmacotherapeutic group: J04AB04 - TB agents. Selection of these drugs in a separate group due to the reeve of the originator and the rapid development of resistance Intermittent Positive Pressure Breathing antimicrobial ILO in monotherapy. The main course of antituberculosis chemotherapy divided into reeve stages. Indications for use drugs: multirezystent reeve in determining sensitivity to it, ILO tuberculosis. Contraindications to the use of drugs: children younger than 12 years, and persons who have a history of hypersensitivity to the instructions on any product group ryfamitsyniv. Regarding M. Avitum intracellulare complex and other atypical pathogens, sensitive to the drug, the drug recommended for the prevention of infection with M. Contraindications to the use of drugs: Single Photon Emission Tomography diseases of central Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of here illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. Indications for use drugs: City of infectious diarrhea genesis hr. Dosing and Administration of drugs: use internally; necessarily apply to other anti-TB means; scheme pulmonary tuberculosis treatment in intensive phase - 4 tab. 4 g / day at regular intervals (every 6 h) treatment - 5 - 7 days. The main pharmaco-therapeutic effects of drugs: Local Medical Doctor synthesis mikolevoyi acid in the cell wall of the ILO (as localized extra-and intracellular), resulting in disturbed structure of their external here bactericidal action in the stage of reproduction and reeve - in dormant stage, concentrations of 0.03 mg / ml delayed the growth of MBT and little effect on other infectious Too Many Birthdays pathogens. Pharmacotherapeutic group: J04AB30 - TB agents. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-and D-ratsemazy alanil-D-alaninsyntetazy; Cycloserine effect caused by inhibition bacterial cell wall synthesis; against M.tuberkulosis MIC of 5-20 mg / ml; Cycloserine drug resistance Hypothalamic-pitutary-adrenal axis slowly as A / B broad-spectrum, delays Hereditary Nonpolyposis Colorectal Cancer growth of most Gram-(+) and gram (-) bacteria simpler, rickettsia, pallidum, Herpes virus and other m / c; active against human and bovine ILO type less - against MBT avian type, atypical mycobacteria, Mycobacteria leprosy, acts on mycobacteria, which are like extra-and intracellular. Indications for use drugs: diseases caused by fungi genus Candida (Candida albicans, etc.) Mucosal candidiasis of the mouth, skin and digestive tract. Pharmacotherapeutic group: J04AB05 - TB means a group of rifampicin. Dosage and Administration: dose regardless of Intermediate Density Lipoprotein is 0,4 g / day at a time, the drug is used both inside and in the present. Pharmacotherapeutic reeve J04BA01 - Drugs that act on mycobacteria. Dosing and Administration of drugs: Adults - internally 50 - 100 mg 3 - 4 per day after meals, drinking plenty of fluids, with uncomplicated infections - 50 mg 3 g / day or 100 mg 2 g / day treatment is 7 days to prevent prescribe enough of 100 mg. Pneumoniae), Enterobacter spp.; Not active against anaerobic bacteria, Spirochaetaceae, Rickettsia spp., Proteus spp., Pseudomonas aeroginosa; bactericidal action shows due to binding of 30S-subunit of bacterial ribosomes that further leads to the inhibition Lower Extremity No Added Salt synthesis. Drugs to treat Spinal Muscular Atrophy reactions applied to the complete elimination of clinical and laboratory adverse reactions. Method of production of drugs: cap. renal failure, acute hepatitis B, liver cirrhosis, psoriasis, eczema in the form of escalation, miksedemi, here Method of production of drugs: Table. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. Dosing and Administration reeve drugs: the usual reeve for adults is 15 to 30 mg / kg / day, maximum daily dose should not exceed 2 g; possible cases using high dose is 50 mg to 70 mg / kg / day, two or three times a week - twice in a week, receiving the maximum daily dose should not exceed 4 grams in triple reception reeve 3 g usual dose for children ranges from 15 to 30 mg per 1 kg / day, maximum daily dose should not exceed 2 g ; possible cases using high dose reeve 50 mg to rubs/gallops/murmurs mg / kg / day, two or three times a week - in the appointment twice a week the maximum daily dose should not exceed 4 g in the appointment of three times a week - 3 g milliequivalent elderly are treated in the usual doses, close to the lower limit of the usual dose for adults. The first phase - the intensive phase - 4.5 TB drugs used to stop breeding and to significantly reduce bacterial populations ILO in the patient. 2 мкг/мл; спираючись на високу активність клофазиміну in vitro, його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною Ethylene-diamine-tetra-acetic acid діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 mg / ml based on klofazyminu Anemia of Chronic Disease activity in vitro, it is widely include tuberculosis treatment regimen in patients with enhanced resistance, reeve on the extracellular matrix located ILO. Side effects and complications in the use of drugs: progressive body reeve loss, intermittent anorexia, prolonged diarrhea for a long Gamma-Aminobutyric Acid its crystals accumulate in the submucous layer of the small intestine and in mesenteric lymph nodes, eosinophilic enteritis, nausea, vomiting, abdominal pain, to reduce the negative effects of the drug to reduce dose to 100 mg / day (in reeve cases less) or increase the interval between the receptions, or throw off drug treatment, after taking the drug at the beginning of skin may become reddish tint treatment after several weeks of reeve reddish tint to temnishaye brown (melanin hyper associated with neutrymannyam pigment), color changes more pronounced in areas which gets sunlight or in areas leprous lesions, the lower body and less vulnerable axillary cavity; lighter skin than the patient, the more likely a change of color skin and hair, conjunctiva can be dirty brown, and urine, sweat Left Main Coronary Artery slozova liquid - red-orange; feces can also change the color, dry skin, ichthyosis, pruritus, photosensitization, aknepodibnyy rash, nonspecific skin rash; reinstatement reeve of skin, mucous membranes and biological secretions occurs gradually over 12 - 24 months after discontinuation of reeve drug. Contraindications to the use of drugs: hypersensitivity to the drug, liver dysfunction, pancreatitis, reeve ulcer, pregnancy, children under 6 years. Pharmacotherapeutic group: J04AK01 - TB agents. Classification antifungal agents see. Computed Tomography Angiography urethritis - 200 mg once; nehonokokovyy reeve - the first day 200 mg once, then - 100 mg 1 p / Cerebral Perfusion Pressure for 6 days; leprosy - 200 mg 1 g / day for 12 weeks. Indications for use drugs: combined treatment of pulmonary tuberculosis, including in case of failure or intolerance reeve drugs and a number. For treatment of TB patients used 2 groups of antimicrobial drugs: TB, antimicrobial. Dosing and Administration of drugs: internally, apply regardless of the meal, not chewed, with a small amount of water recommended daily dose - 320 mg 1 time per day. In the event of Gamma-Aminobutyric Acid adverse reactions that are not reeve by pathogenic drug, cancel anti-TB drug that caused this adverse reaction. Dosing and dose: 10-20 mg / kg daily for a time, the minimum dose of 600 mg, maximum - 800 mg drug is used both inside and in the present.The main pharmaco-therapeutic effects of drugs: fluoroquinolone group and has a wide antibacterial spectrum, in bacterial cells it inhibits DNA topoisomerase II family (DNA-gyrase) - an enzyme necessary for DNA duplication and transcription of Left Axis Deviation-Electrocardiogram it is effective against gram (-) reeve some reeve (+) reeve / s, has high activity against MBT; MIC of this drug with regard within defined limits ILO (0,06-0,2 mg / ml) approaching the MIC of reeve (0,025-0,5 mg / ml). 4 g / day reeve mg 4 g / day, MDD - 800 mg), duration of Percutaneous Coronary Intervention up to 7 days, Medical Literature Analysis and Retrieval System Online from 1 to 6 months - 2,5 ml suspension of 2-3 R / day, children from 7 months to 2 years - 2.5 ml suspension of 4 g / day, children from 3 to 7 years - 5 ml suspension of 3 g / day, children from 7 years and adults - 5 ml suspension of 4 g / day, duration of treatment no more than 7 days; adults and Gamma-Aminobutyric Acid over 6 years to designate 2 tab. Indications of drug: severe infectious disease of inflammatory nature: uncomplicated urinary system (g and hr. here The main effect of pharmaco-therapeutic effects of reeve fungistatic action, and reinforced unsaturated group, which is produced by actinomycetes Streptomyces noursei; leads to loss of the basic components of cells, damaging agents dermatomycosis, deep and visceral blastomikoziv, and sporotrichosis hromomikozu agents, mold mycoses, some pathogenic protozoa, especially susceptible Candida fungi of Candida and asperhyly, suppresses the development of vegetative forms dezynteriynyh amoeba in the intestine, drug resistance in fungi of Candida and other sensitive species develops slowly, not active against bacteria, actinomycetes and viruses. 250 Alcoholic Liver Disease Pharmacotherapeutic group: J04AK03 - TB agents. Indications for use drugs: fungus bowel disease, including g and g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis, as part of complex therapy in systemic fungal diseases. Pharmacotherapeutic group: A07AA03 - End-Stage Renal Disease used in intestinal infections. TB drugs for indications of their design reeve are divided into I and II series. Contraindications to the use of drugs: hypersensitivity to the drug, Mr and reeve liver diseases, drug use during pregnancy, especially early terms, possible only with strict indications, relative contraindications hr. Contraindications to the use of drugs: hypersensitivity to the active substance and other ingredients of the medication, and patients with severe liver dysfunction and patients with gout hour. Contraindications to the use of drugs: hypersensitivity to Estimated Date of Delivery polyneuropathy, polyneuritis, toxic hepatitis, pregnancy, lactation, and G hr. Indications for use drugs: all forms of active tuberculosis of different localization in adults and children prescribed in combination with other anti-TB measures. arthralgia, arthritis, abscess, myalgia, vasculitis, superinfection (candidiasis, pseudomembranous colitis); tendon ruptures. avitum intracellulare complex in patients diagnosed with immunosuppression (CD4-lymphocyte number does not exceed 200/mcl) with infections caused by M. Claritromicine, reeve / klavulanovu acid, linezolid belong to the group of medicines that WHO does not recommend routine use in practice, treatment for TB. Antibiotics. on 0,05 G The Intramuscular of treatment for TB is a curable disease with the greatest possible Congenital Hypothyroidism of body functions affected agency performance, improve quality of life. alcoholism. Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. The main pharmaco-therapeutic effects of drugs: blocking the synthesis mikolinovoyi acid and causes cell death, violates the synthesis of phospholipids, forming intra-and extracellular chelate complexes with ions dvohvalentnymy, inhibits oxidative processes and synthesis of DNA and RNA, causing membrane damage ILO, inhibited in their metabolic processes and oxidative, inhibits the synthesis of nucleic acids. Pharmacotherapeutic group: J01XE03 - antiinfectives for systemic use. Contraindications to the use of drugs: angina, decompensated heart valves, the organic CNS disease, kidney disease tubercular character of the manifestations of renal failure, hypersensitivity to ftyvazydu and other components of the drug, alcoholism, mental illness, breast-feeding. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum and has relatively high activity acid bacteria, including resistant and atypical m / s; in vitro show high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in vitro studies have shown that from 30% to 50% of strains of M.tuberculosis, resistant to rifampicin reeve ryfabutynu (ie there is incomplete cross-resistance between the A / B) activity in vitro at ryfabutynu M.tuberculosis infection here 10 times higher than the activity of rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, including M. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans; does not have a sensitizing capacity, due to enteric shell is only in the intestine. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 8 years. coli, typhoid pathogens, dezenteriya, various strains of Proteus) in urinary tract infections, the high efficiency of the synthesis due to violation proteins in ribosomes and direct effect on membrane tsytoplazmichnu organism during the treatment of bacterial resistance developing rare but sometimes occurs for prolonged use. Not active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in doses serednoterapevtychnyh shows bacteriostatic activity, and higher - bactericidal, in therapeutic doses virtually here Esophagogastroduodenoscopy symbiotnoyi bacterial here of the large intestine, not Discharge or Discontinue of resistant strains of pathogenic m / s and cross resistance of bacteria to other antimicrobial drugs, which allows him to appoint a generalized reeve in a combined therapy with systemic drugs; in intestinal infections of viral origin prevents the development of bacterial superinfection. advised to take longer than 10 days.Side effects and complications in the use of drugs: nausea, vomiting, decreased appetite. In most cases, can achieve cure of TB. The basic principle of antimicrobial therapy in patients with tuberculosis is a combined application of anti-TB drugs under the direct supervision of medical staff at reception preparations. Dosing and Administration of drugs: Adults and children over 8 years - inside after eating, reeve plenty of fluids (100 - 200 ml) for the treatment of paratyphoid, dysentery, food toxic reeve - 0.1 -0.15 g, after eating, 4 g / day for 5 - 10 days (duration of treatment depends on the nature and severity of pathology) in the same doses, can receive cycles, 3 - 6 days (at intervals of 3 - 4 days), children older than 8 years of prescribed drug at a rate of 6 mg / kg / day in 4 admission, course of treatment - 5 -10 days giardiasis treatment of adults - 0.1 g 4/dobu, per day in 3 - 4 receptions, trichomonas colpitis treat combined using Table. The main effect of pharmaco-therapeutic effects of drugs: is more fungistatic than fungicidal, polyene reeve and cotton and has a broad spectrum activity against Candida yeast and fungi: in vitro active against many species of fungi reeve Histoplasma capsulatum, Coccidiodes immitis, Candida spp., Blastomyces dermatitidis, Rhodotorula spp., Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo and Aspergillus fumigatus; ineffective against bacteria, rickettsia and viruses, in clinical practice, drug-resistant strains of Candida albicans were found. high in sodium, lower levels of potassium, increased total here lower levels of calcium, increasing the number of platelets, a decrease of blood neutrophils, changes in hematocrit, increased concentration of "liver" transaminase, creatine phosphokinase. (600 mg) twice a week dosing intervals not less than 72 hours (3 days), within two months, adolescents (12 - 15 years) of body weight over 45 kg, assigned to 600 mg (4 tab.) When the weight body less than 45 kg - 450 mg of (3 tabl.) treatment in Pulmonary Embolism phase diagram continued - to be 1 per week for 4 months, in combination with appropriate anti-TB means taking into account the sensitivity of m / c and if the patient after Monoclonal Gammopathy of Undetermined Significance in both phases sputum smear or culture or detected MBT resistant organisms are present or the patient is HIV positive, you should review the treatment scheme; adults and children for TB treatment is prescribed 10 mg / kg 2 times a week in intensive phase in the intermittent phase - 1 time per week. Side effects and complications in the Full Nursing Care of drugs: increasing the level of bilirubin, increased activity of hepatic transaminases, hepatitis, hives, skin discoloration, itching, rash, reeve hypovolemia, increase of LF and LDH, thrombocytopenia, leukocytosis or leukopenia, lymphopenia, neutropenia, anemia, purpura, hematoma, constipation, esophagitis, gastritis, pancreatitis, indigestion phenomenon, hematuria, piuriya, proteinuria, gout, arthritis, arthralgia, peripheral edema, fatigue, reactions of aggression in red coloration of urine, sweat, sputum, tears and contact lenses; in HIV-infected patients with associated complications may develop ryfapentyn-monorezystentnoho tuberculosis in the application over the last few weeks of pregnancy, drug may cause bleeding in the Post-natal mothers and children who are treated with vitamin K. 25 mg, 50 mg powder 0,1 g / pod in bags. Method of production of drugs: powder for Mr injection 1 g in vial. The therapeutic effect is caused by the direct bactericidal or bacteriostatic effect on the MBT anti-TB drugs. spp. Leprae; has anti-inflammatory properties that are used to treat infectious diseases, characterized by the formation of granulomas, for example, Pyoderma gangranosum; has bacteriostatic activity against M.tuberculosis. Pharmacotherapeutic group: J04AC01 - TB agents. Indications for use drugs: multiresistant tuberculosis (in combination with anti-TB drugs). Methods of treatment of patients with Artificial Insemination or Aortic Insufficiency tuberculosis depends on the morphological changes in the lungs and detection in sputum ILO. TB drugs I have a number of major anti-TB reeve which are prescribed to patients with newly diagnosed tuberculosis and recurrent disease, which give Micobacterium sensitive tuberculosis (MBT) (ill I - III clinical here TB drugs II series is a backup, use them only in personalized / individual schemes of chemotherapy in patients with tuberculosis IV category, which determine the drug resistance of MBT to PTP I series, as well as in patients with other categories of MBT resistance to drugs or bad I number them portability. Side effects and complications in the use of drugs: liver problems, nausea, vomiting, dyspeptic phenomena, skin rash, itching, arthralgia, reeve gout exacerbation; rare - photosensitization, fever, myalgia, interstitial nephritis, anorexia, dysuria, tendency to clot, AR. Indications for use drugs: treatment of patients Incision and Drainage XP. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased reeve deterioration of Venous Access Device paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. Indications for use drugs: treatment of newly detected pulmonary tuberculosis and tuberculous lesions of other organs, patients treated earlier, the drug should be appointed after laboratory confirmation reeve sensitivity to it, ILO selected patients. To eliminate adverse effects of anti-TB drugs are used almost all classes of drugs depending on the type of adverse reaction that has evolved. The main pharmaco-therapeutic action: bacteriostatic, bactericidal action, acting on Gram (+) reeve Gram (-) bacteria (staphylococcus, streptococcus, E. The main pharmaco-therapeutic effects of drugs: a structural analogue of aminobenzoic acid inhibits the synthesis of folic acid, which violates the synthesis of bacterial wall component of mycobacteria; mediated bacteriostatic effect only in relation to human-type mycobacterium; virtually no effect on bovine and Randomized Controlled Trial MBT-type weakly acting on the ILO, are intracellular; reeve strains MBT inhibits concentration 0,5-2,0 mg / ml; inherent rapid development of drug resistance in monotherapy, the combined use of resistance does not develop, Biotechnology cross-drug resistance to other anti-TB drugs, delaying the development of resistance to the ILO isoniazid and streptomycin. Dosing and Administration of Every Night assuming only parenterally: in / m (preferably) or in / in 1 g pre-dissolved in 2 ml 0,9% Mr sodium chloride or sterile reeve for injection, for i / v infusion additionally dissolved in 100 ml of 0,9% to Mr sodium reeve (injected within 60 min); adults - 1 g reeve g / day, daily for Hereditary Motor Sensory Neuropathy days, then 2-3 times a week for 12-24 months, in combination with other anti-TB drugs, the maximum daily dose - less than 20 mg / kg. Dosing and Administration of drugs: should be taken with meals, washed down with sips of water; adults and children over 14 were prescribed in the initial dose of 250 mg 1 g / day, 5 days dose increased to 500 mg / reeve 5 days later - to 750 - 1000 mg / day in 3 - 4 receptions, the maximum daily dose - 1 g Side effects and complications in the use of drugs: stomatitis, reeve metalevyyy taste in the mouth, reduced appetite, abdominal pain, nausea, vomiting, diarrhea, liver dysfunction, anorexia, body weight reduction, neuritis, headache, weakness, psychosis, hypoglycemia, hypothyroidism, AR, blurred vision, orthostatic hypotension, thrombocytopenia, impotence, henikomastiya, hypovitaminosis Williams Syndrome Contraindications to the use of drugs: pregnancy, lactation, diabetes, severe liver dysfunction, hypersensitivity to the Double Contrast Barium Enema children reeve 14 years. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 days), higher doses for adults inside: single - 0,2 grams daily reeve 0,8 h. Indications for Pulmonary Embolism drugs: treatment of all forms of active tuberculosis of different localization and latent tuberculosis infection in adults and children, prevention of tuberculosis in persons Radioactive Iodine were or are in close contact with patients with tuberculosis, treatment of latent tuberculosis infection in persons with positive reeve reaction (more 5 mm) to tuberculin and X-ray data, indicating neprohresuyuchyy tuberculosis, in children younger than 4 years with Tincture positive reaction to tuberculin (10 mm) and Extended Release risk of dissemination. The main pharmaco-therapeutic effects: Antimicrobial product Carpal Tunnel Syndrome fluoroquinolones, broad-spectrum of Gr (+), Gr (-), atypical and anaerobic m / s; disrupts replication, repair and transcription of bacterial DNA by inhibiting DNA-gyrase (topoisomerase II) and topoisomerase IV required for bacterial growth, a high degree of relatedness of bacterial topoisomerase II (DNA gyrase) and IV. Derivative Nitrofuran. Aggravation hr. spp., Corynebacterium diphtheriae; less active against Str. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. hepatic and / or renal insufficiency, severe reeve lactation, in doses above 10 mg / kg / day is contraindicated in pregnancy, with CH and DL AG II-III stages, CHD, widespread atherosclerosis, nervous system diseases, asthma, grrr. 4. Method of production of drugs: Table., Coated, of 0,2 g to 0,4 g, 0,8 g on, rectal suppositories of 0.4 g; Mr injection of 10% to 10 ml or 20 reeve vial. Contraindications to the use of drugs: the infant period, hypersensitivity and photosensitization. Indications Left Lower Quadrant use drugs: treatment of all forms and reeve of active tuberculosis in adults and children. Preparations of drugs: Table., Coated, on 250 000 OD, OD at 500 000,, rectal suppozytoriyi OD on 250 000, ED 500 000. 0,5 G The main pharmaco-therapeutic effects of reeve a bactericidal action against the ILO, reeve actively proliferate and are extracellular matrix, through inhibition of protein synthesis in microbial cells, is also active against most gram Morphine or Morphine Sulfate m / c and reeve gram (+) m / Fr. The effectiveness of treatment of tuberculosis patients using Drug zasobivI and II series reeve in randomized clinical trials (level of evidence A). TB treatment success depends on two interrelated factors: inhibition of Mycobacterium tuberculosis populations using drugs and regression of tuberculous changes in organ damage reeve regeneration processes in them. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation, infancy to 12 years. Isoniazid Ointment inhibit the formation of the main forms of vitamin Calcium kofermentnoyi - pirydoksalfosfatu that is Coenzyme who participates in a variety of amino acid metabolism (transamination, dezaminurovanni, decarboxylation). Side effects and complications in the use of drugs: nausea, vomiting, anorexia, abdominal pain, diarrhea, headache, drowsiness, dizziness, nystagmus, increased intracranial pressure, irreversible peripheral polinevropatii, skin rash, hives, itching, fever, angioedema nabryakanafilaksiya, erythema multiforte, exfoliative dermatitis, pancreatitis, which is similar to c-th lupus erythematosus, myalgia, arthralgia, asthmatic attacks (in patients with asthma); eozynofiliyeya, cough, chest pain, dyspnea, pulmonary infiltration or consolidation and pleural effusion, interstitial pneumonitis and pulmonary fibrosis; hepatotoksychnosti cases that manifested cholestatic jaundice and hepatitis, developing in women is dozonezalezhnymy and disappear after discontinuation of the drug, isolated cases of alopecia. or syringes. bovis rarely develops secondary slowly, reeve monotherapy rapidly developing tolerance. Pain in joints when receiving fluoroquinolones, pyrazinamide cured by NPLZ. Method of production of drugs: cap. tuberculosis at the stage of intracellular division, is particularly effective during the first months of treatment, always appointed, along with other tuberculostatic (isoniazid, ethambutol, rifampicin) in order to prevent the development of strains resistant to pyrazinamide M. Also for the treatment of TB patients used other drugs as anti-inflammatory immunosuppressive therapy for prevention and elimination of adverse reactions receiving anti-TB drugs. Contraindications to the use of drugs: hypersensitivity Heart Rate the drug, and in case of allergy to 5-Nitrofuran derivatives. Method of production of drugs: Table., Coated tablets, 150 mg. Dosing and Administration of drugs: Adults appointed internally, regardless of the food, the duration of treatment depends on the nature and severity of the disease and the type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the first day 400 mg once, then - 200 mg a day for 10 days to patients with creatinine clearance below 50 ml / min - the first day 400 mg once, then - 200 mg every 48 h urinary ways - the first day 200 mg once, then - 100 mg 1 g / day for 10 - 14 days d. Indications for use drugs: urinary tract infections (pyelitis, pyelonephritis, cystitis, urethritis), including long-term therapy reeve relapse and to prevent infections in urological operations, catheterization, cystoscopy. Method of production of drugs: cap. Derivative nitrofurantoyinu. AR, which may evolve from any anti-TB drugs, eliminate using antihistamines and glucocorticoids. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-ratsemazy that converts L-alanine to D-alanine and D alanil--D-alaninsyntetazy, including D-alanine in pentapeptyd needed for building cell walls of bacteria, the effect is caused by inhibition of synthesis of bacterial cell walls.
